[Comment] G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults

Ending tuberculosis is more than just a global health necessity; it is fundamental to sustainable development and global health security. With at least 10 million new cases and more than 1 million deaths annually, tuberculosis is one of the leading causes of death globally, the leading cause of death in people living with HIV, and a substantial cause of morbidity and mortality from antimicrobial resistance.1